Zhong, Zhixiong <br/><br/>
Effect of cytochrome P450 2C19 polymorphism on adverse cardiovascular events after drug-eluting stent implantation in a large Hakka population with acute coronary syndrome receiving clopidogrel in southern China.  [electronic resource] 

 -  European journal of clinical pharmacology  Apr 2018 
 - 423-431 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1432-1041 
<br/><br/><label>Standard No.: </label>10.1007/s00228-017-2393-1  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acute Coronary Syndrome--diagnostic imaging<br/>Adenosine--analogs & derivatives<br/>Aged<br/>Asian People--genetics<br/>Chi-Square Distribution<br/>China<br/>Clinical Decision-Making<br/>Clopidogrel<br/>Cytochrome P-450 CYP2C19--genetics<br/>Drug-Eluting Stents<br/>Female<br/>Gene Frequency<br/>Genetic Predisposition to Disease<br/>Hemorrhage--chemically induced<br/>Heterozygote<br/>Homozygote<br/>Humans<br/>Hypertension--complications<br/>Kaplan-Meier Estimate<br/>Logistic Models<br/>Male<br/>Middle Aged<br/>Myocardial Infarction--blood<br/>Percutaneous Coronary Intervention--adverse effects<br/>Pharmacogenetics<br/>Pharmacogenomic Variants<br/>Phenotype<br/>Platelet Aggregation Inhibitors--adverse effects<br/>Polymorphism, Genetic<br/>Precision Medicine<br/>Retrospective Studies<br/>Risk Factors<br/>Stroke--blood<br/>Ticagrelor<br/>Ticlopidine--adverse effects<br/>Treatment Outcome